Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2025, Sabra Healthcare (SBRA) reported revenue of $183.54 million, up 10.1% over the same period last year. EPS came in at $0.37, compared to $0.11 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $181.82 million, representing a surprise of +0.95%. The company delivered an EPS surprise of +2.78%, with the consensus EPS estimate being $0.36.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Sabra performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Interest and other income: $10.06 million versus $9.43 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +12.5% change.
• Revenues- Resident fees and services: $77.45 million versus $77.98 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +17.3% change.
• Revenues- Rental and related revenues: $96.04 million compared to the $97.02 million average estimate based on two analysts. The reported number represents a change of +4.6% year over year.
• Net Earnings Per Share (Diluted): $0.17 versus $0.17 estimated by three analysts on average.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research